Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Clinical outcomes of open-wedge corrective osteotomy using autogenous or allogenic bone grafts for malunited distal radius: A novel parameter for measuring the rate of bone union.

Authors:
Jae-Hoo Lee Gwan-Ho Kim Min-Jong Park

Acta Orthop Traumatol Turc 2022 May;56(3):199-204

Department of Orthopaedic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Objective: The aims of the study were (1) to compare outcomes in terms of malunited distal radius bone union in open-wedge corrective osteotomy using autogenous or allogenic bone and (2) to introduce a new parameter that quantifies the rate of the bone union.

Methods: This retrospective study included 22 patients (14 males, 8 females) who underwent open-wedge corrective osteotomy with bone grafting for a malunited distal radius fracture between January 2006 and December 2018 were enrolled. The mean follow-up duration was 57.2 weeks (SD 46.1, range 12-206). All the patients were then divided into 1 of the 2 groups based on the graft material used: autog- enous bone graft group (n=10, 5 males and 5 females) and allogenic bone graft group (n=12, 9 males and 3 females). We introduced the "duration of union/correction gap ratio" to represent the healing potential of each graft materials. Radiologic parameters including initial correction gap, radial inclination, radial length, palmar tilt, and ulnar variance were also measured pre- and postoperatively. Functional outcomes were assessed by grip strength, range of motion, and the disability of the Arm, Shoulder, and Hand score.

Results: Of the 22 patients, 16 (72.7%) achieved complete union within 12 weeks, 3 (13.6%) in over 12 weeks, and the other 3 (13.6%) showed nonunion. Excluding the 3 nonunion cases, the mean union duration was 10.6 weeks, and the mean correction gap was 10 mm. The mean correction gap was wider in the autogenous bone graft group, and the mean union duration was longer in the allogenic bone graft group. Autogenous bone grafts had a significantly lower duration of bone union/correction gap ratio than allogenic bone grafts (0.76 vs. 1.61, P < 0.001). According to the correction method (simple open-wedge corrective osteotomy vs. open-wedge corrective oste- otomy OWCO), only duration of bone union/correction gap ratio reflected the actual difference between values.

Conclusion: Despite autogenous bone graft donor site morbidities, in our study, autogenous bone showed better bone healing potential than allogenic bone. In terms of bone union, autogenous bone has the benefit of better union in larger gaps than allogenic bone. Surgeons can take advantage of the newly introduced "duration of bone union/correction gap ratio" to compare the bone healing potential by graft materials or surgical options.

Level Of Evidence: Level IV, Therapeutic Study.

Download full-text PDF

 Source
http://dx.doi.org/10.5152/j.aott.2022.21140DOI Listing
May 2022

Publication Analysis

Top Keywords

allogenic bone
28
bone
23
open-wedge corrective
20
bone graft
20
autogenous bone
20
union/correction gap
16
corrective osteotomy
16
graft group
16
bone grafts
12
males females
12
distal radius
12
healing potential
12
malunited distal
12
bone union/correction
12
correction gap
12
bone union
12
weeks 136%
8
rate bone
8
union duration
8
graft
8

Keyword Occurance

Similar Publications

Adult allogenic bone marrow-derived mesenchymal stem cells for the treatment of rectovaginal fistulas in the setting of Crohn's disease.

Authors:
A M Otero-Piñeiro A L Lightner

Tech Coloproctol 2022 Aug 1. Epub 2022 Aug 1.

Department of Colorectal Surgery, Digestive Disease Surgical Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA.

View Article and Full-Text PDF
August 2022
Similar Publications

Transplantation of insulin-producing cells derived from human mesenchymal stromal/stem cells into diabetic humanized mice.

Authors:
Mohamed A Ghoneim Mahmoud M Gabr Ayman F Refaie Sawsan M El-Halawani Mohga M Al-Issawi Batoul L Elbassiouny Mai A Abd El Kader Amani M Ismail Mona F Zidan Mary S Karras Raghda W Magar Sherry M Khater Sylvia A Ashamallah Mahmoud M Zakaria Malgorzata Kloc

Stem Cell Res Ther 2022 07 26;13(1):350. Epub 2022 Jul 26.

The Houston Methodist Research Institute, Houston, TX, USA.

Background: The purpose of this study was to investigate allogenic immune responses following the transplantation of insulin-producing cells (IPCs) differentiated from human adipose tissue-derived stem cells (hAT-MSCs) into humanized mice.

Methods: hAT-MSCs were isolated from liposuction aspirates obtained from HLA-A2-negative healthy donors. These cells were expanded and differentiated into IPCs. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

The results of allogenic cancellous bone graft in medial opening wedge high tibial osteotomy.

Authors:
Hamid Reza Yazdi Hosein Karimi Haris Setareh Rohani Neamat Karimi

Eur J Orthop Surg Traumatol 2022 Jul 22. Epub 2022 Jul 22.

Department of Clinical Biochemistry, Cancer Research Laboratory, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Purpose: There is no clear consensus regarding the optimal filling agent in the medial opening wedge high tibial osteotomy (MOWHTO). In this study, we evaluated the clinical and radiologic outcomes of MOWHTO with an allogeneic cancellous bone graft and TomoFix plate.

Methods: Medical profiles of 122 patients who underwent MOWHTO with cancellous bone graft from iliac crest were retrospectively reviewed. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Immune reconstitution after allogenic stem cell transplantation: An observational study in pediatric patients.

Authors:
Aline Risson Belinovski Polliany Dorini Pelegrina Alberto Cardoso Martins Lima Cilmara Cristina Kuwahara Dumke Adriana Mello Rodrigues Gisele Loth Fernanda Moreira de Lara Benini Ana Luiza Melo Rodrigues Fábio Araujo Motta Carolina Prando Carmem Bonfim

Hematol Transfus Cell Ther 2022 Jul 7. Epub 2022 Jul 7.

Hospital Pequeno Príncipe, Curitiba, PR, Brazil; Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba, PR, Brazil; Faculdades Pequeno Príncipe, Curitiba, PR, Brazil.

Introduction: The immune reconstitution (IR) after the allogenic hematopoietic stem cell transplantation (allo-HSCT) is a progressive process intrinsically correlated to the therapeutic success. It is essential to understand the interfering factors in IR to prevent the HSCT-related mortality.

Methods: We retrospectively evaluated the clinical outcomes, absolute lymphocyte counts (ALCs) and lymphocyte subtypes at different time-points of 111 pediatric patients with allogeneic HSCT for malignant and non-malignant diseases from 2013 to 2018. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia: an overview of prevention and treatment.

Authors:
Firas Kreidieh Iman Abou Dalle Nour Moukalled Jean El-Cheikh Eolia Brissot Mohamed Mohty Ali Bazarbachi

Int J Hematol 2022 Jul 16. Epub 2022 Jul 16.

Department of Internal Medicine, Medical Center, Bone Marrow Transplant Program, American University of Beirut, Beirut, Lebanon.

Despite therapeutic progress in acute myeloid leukemia (AML), relapse post-allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains a major challenge. Here, we aim to provide an overview of prevention and treatment of relapse in this population, including cell-based and pharmacologic options. Post-transplant maintenance therapy is used in patients who have undetectable measurable residual disease (MRD), while pre-emptive treatment is administered upon detection of MRD. Read More

View Article and Full-Text PDF
July 2022
Similar Publications
}